Acot1 and Cyp4a1 Genes are involved in Castor Leaf Extract-Induced Hepatoprotection of Rats doi.org/10.26538/tjnpr/v4i11.11
Main Article Content
Abstract
Several plant families were used as medicines for treating various diseases. Ricinus communis (Castor) has antioxidant, anti-inflammatory, and hepatoprotective properties that substantiated its use for treating inflammation and liver disorders. In the present study, the hepatoprotective effects of the ethanol extract of Castor leaves against carbon tetrachloride (CCl4)-induced liver injury was investigated in rats. The results indicated that an increase in the levels of liver alanine amino transferase, alkaline phosphatase, and lipid peroxidation, indicated by malondialdehyde activity, in the CCl4-induced liver injury was significantly reduced in the rats pre-treated with Castor leaf extract. Also, the albumin, catalase, and superoxide dismutase levels were markedly increased in the rats pre-treated with Castor leaf extract compared to reduced levels in the CCl4- injured rats. Based on quantitative real-time-PCR data, our results showed that the increase of acyl-CoA thioesterase-1 (Acot1) in the CCl4-injured rats was reduced in the rats pre-treated with Castor leaf extract. However, the decrease of cytochrome P450-4A-1 (Cyp4a1) in the CCl4- injured rats was alleviated by the pre-treatment of injured rats with Castor leaf extract. Compared to silymarin, the current results approve a hepatoprotective action for the ethanol extract of Castor leaves against CCl4-induced liver injury and propose a role for Acot1 and Cyp4a1 gene expressions in the mechanism of hepatoprotection.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
Mohamed NZ, Abd-Alla HI, Aly HF, Mantawy M, Ibrahim N, Hassan SA. CCl4-induced hepatonephrotoxicity: protective effect of utraceuticals on inflammatory factors and antioxidative status in rat. J Appl Pharm Sci. 2014; 4(2):087- 100.
Gulati K, Reshi MR, Rai N, Ray A. Hepatotoxicity: Its Mechanisms, Experimental Evaluation and Protective Strategies. Am J Pharmacol. 2018; 1(1):1004.
Meng X, Li Y, Li S, Gan RY, Li HB. Natural Products for Prevention and Treatment of Chemical-Induced Liver Injuries. Compr Rev Food Sci Food Saf. 2018; 17(2):472-495.
Knowles SR, Uetrecht J, Shear NH. Idio-Syncratic drug reaction: The reactive metabolite syndromes. Lancet 2000; 356(9241):1587-1591.
Li S, Tan HY, Wang N, Zhang ZJ, Lao L, Wong CW, Feng Y. The role of oxidative stress and antioxidants in liver diseases. Int J Mol Sci. 2015; 16(11):26087-26124.
Li Y, Zhang JJ, Xu DP, Zhou T, Zhou Y, Li S, Li HB. Bioactivities and health benefits of wild fruits. Int J Mol Sci. 2016; 17(8):1258.
Kashaw V, Amit KN, Abhinav A. Hepatoprotective prospective of herbal drugs and their vesicular carriers- a review. IJRPBS. 2011; 2(2):360-374.
Bedi O, Bijjem KVR, Kumar P, Gauttam V. Herbal induced hepatoprotection and hepatotoxicity: a Critical review. Indian J Physiol Pharmacol. 2016; 60(1):6-21.
Hellerbrand C, Schattenberg JM, Peterburs P, Lechner A, Brignoli R. The potential of silymarin for the treatment of hepatic disorders. Clin Phytosci. 2017; 2(1):7.
Anthony K and Saleh M. Free radical scavenging and antioxidant activities of silymarin components. Antioxidants 2013; 2(4):398-407.
Weiss EA. Oilseed crops. (2nd ed.) Oxford: Blackwell Science; 2000. 364 p. 12. Jena J and Gupta AK. Ricinus communis Linn: a phytopharmacological review. Int J Pharm Pharm Sci 2012; 4(4):25-29.
Darmanin S, Wismaver PS, Camillerri Podesta MT, Micallef MJ, Buhagiar JA. An extract from Ricinus communis L. leaves possesses cytotoxic properties and induces apoptosis in SKMEL- 28 human melanoma cells. Nat Prod Res. 2009; 23(6):561-571.
Abdul WM, Hajrah NH, Sabir JS, Al-Garni SM, Sabir MJ, Kabli SA, Bora RS. Therapeutic role of Ricinus communis L. and its bioactive compounds in disease prevention and treatment. Asian Pac J Trop Med. 2018; 11(3):177-185.
Kirkby B, Roman N, Kobe B, Kellie S, Forwood JK. Functional and structural properties of mammalian acylcoenzyme A thioesterases. Prog Lipid Res. 2010; 49(4):366-377.
Dongol B, Shah Y, Kim I, Gonzalez FJ, Hunt M. The acylCoA thioesterase I (Acot1) is regulated by the peroxisome proliferator-activated receptor alpha and hepatocyte nuclear factor 4 alpha via a distal response element in the promotor. J Lipid Res. 2007; 48(8):1781-1791.
Guengerich FP. Cytochrome p450 and chemical toxicology. Chem Res Toxicol. 2008; 21(1):70-83.
Xu L, Das B, Prakash C. CYP 450 Enzymes in Drug Discovery and Development: An Overview. In: Lyubimov AV (Ed). Encyclopedia of drug metabolism and interactions. New Jersey: Wily; 2012. 1-35 P.
Elshater AEA, Salman MMA, Mohamed SA. The hepatoameliorating effect of Solanum nigrum against CCl4 induced liver toxicity in Albino rats. Egypt Acad J Biol Sci C Physiol Mol Biol. 2013; 5(1):59-66.
Shahwan M and Al Abdin SMZ. Antioxidant, hepatoprotective and lipid lowering activity of Sarcopoterium Spinosum on carbon tetrachloride (CCl4)-induced hepatic damage in rats. J Pharm Sci Res. 2018; 10(11):2800-2804.
Krithika R and Verma RJ. Solanum nigrum confers protection against CCl4-induced experimental hepatotoxicity by increasing hepatic protein synthesis and regulation of energy metabolism. Clin Phytosci. 2019; 5(1):1.
Okaiyeto K, Nwodo U, Mabinya L, Okoh A. A review on some medicinal plants with hepatoprotective effects. Pharmacogn Rev. 2018; 12(24):186-199.
Solter PF. Clinical pathology approaches to hepatic injury. Toxicol Pathol. 2005; 33(1):9-16.
Ramaiah SK. A toxicologist guide to the diagnostic interpretation of hepatic biochemical parameters. Food Chem Toxicol. 2007; 45(9):1551-1557.
Patrick-Iwuanyanwu KC, Wegwu MO, Ayalogu EO. Prevention of CCl4-induecd liver damge by ginger, garlic and vitamin E. Pak J Biol Sci. 2007; 10(4):617-621.
Ighodaro OM and Akinloye OA. First line defence antioxidants-superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPX): Their fundamental role in the entire antioxidant defence grid. Alexandria Med J. 2018; 54(4):287-293.
Nemudzivhadi V and Masoko P. In vitro assessment of cytotoxicity, antioxidant and anti-inflammatory activities of Ricinus communis (Euphorbiaceae) leaf extracts. J EvidBased Compl Altern Med. 2014; 2014:e625961.
Prince ES, Parameswari P, Mahaboob KR. Protective Effect of Ricinus communis Leaves extract on carbon tetrachloride induced hepatotoxicity in albino rats. Iran J Pharm Res. 2011; 7:269-278.
Babu PR, Bhuvaneswar C, Sandeep G, Ramaiah CV, Rajendra W. Hepatoprotective role of Ricinus communis leaf extract against d-galactosamine induced acute hepatitis in albino rats. Biomed Pharmacother. 2017; 88:658-666
Lien DTP, Hoang CTK, Hanh NT, Chu DX, Tram PTB, Toan HT. Hepatoprotective effect of silymarin on chronic hepatotoxicity in mice induced by carbon tetrachloride. J Pharmacogn Phytochem. 2016; 5(5):462-466.
Jatwa R and Kar A. Protective effect of L-ornithineLaspartate and silymarin on chemically induced kidney toxicity and thyroid dysfunction in mice. EXCLI J. 2008; 7:139-150.
Baradaran A, Samadi F, Ramezanpour SS, Yousefdoust, S. Hepatoprotective effects of silymarin on CCl4-induced hepatic damage in broiler chickens model. Toxicol Rep. 2019; 6:788-794.
Huhtinen K, O’Byrne J, Lindquist PJG, Contreras JA, Alexson SEH. The peroxisome proliferator-induced cytosolic type I acyl-CoA thioesterase (CTE-I) is a serinehistidine-aspartic acid alpha/beta hydrolase. J Biol Chem. 2002; 277:3424-3432.
Fujita M, Momose A, Ohtomo T, Nishinosono A, Tanonaka K, Toyoda H, Morikawa M, Yamada J. Upregulation of fatty acyl-CoA thioesterases in the heart and skeletal muscle of rats fed a high-fat diet. Biol Pharm Bull. 2011; 34:87-91.
Franklin MP, Sathyanarayan A, Mashek DG. Acyl-CoA thioesterase 1 (ACOT1) regulates PPARα to couple fatty acid flux with oxidative capacity during fasting. Diabetes 2017; 66(8):2112-2123.
Yang S, Chen C, Wang H, Rao X, Wang F, Duan Q, Chen F, Long G, Gong W, Zou M-H, Wang D. Protective effects of acyl-coA thioesterase 1 on diabetic heart via PPARa/PGC1a signaling. PLoS One 2012; 7:e50376
Singh PP, Ambika, Chauhan SMS. Activity guided isolation of antioxidants from the leaves of Ricinus communis L. Food Chem. 2009; 114 (3):1069s-1072.
Iqbal J, Zaib S, Farooq U, Khan A, Bibi I, Suleman S. Antioxidant, Antimicrobial, and Free Radical Scavenging Potential of Aerial Parts of Periploca aphylla and Ricinus communis. ISRN Pharma 2012; 2012: 563267.
Pradeep K, Mohan CVR, Gobianand K, Karthikeyan S. Silymarin modulates the oxidant–antioxidant imbalance during diethylnitrosamine induced oxidative stress in rats. Eur J Pharmacol. 2007; 560(2-3):110-116.
Hardwick JP. Cytochrome P450 omega hydroxylase (CYP4) function in fatty acid metabolism and metabolic diseases. Biochem Pharmacol. 2008; 75(12):2263-2275.
Hsu MH, Savas U, Griffin KJ, Johnson EF. Human cytochrome p450 family 4 enzymes: function, genetic variation and regulation. Drug Metab Rev. 2007; 39(2-3):515-538.
Xie Y, Hao H, Wang H, Guo C, Kang A, Wang G. Reversing effects of lignans on CCl4-induced hepatic CYP450 down regulation by attenuating oxidative stress. J Ethnopharmacol. 2014; 155(1):213-221.
Nyagode BA, Jahangardi R, Merrell MD, Tansey MG, Morgan ET. Selective effects of a therapeutic protein targeting tumor necrosis factor-alpha on cytochrome P450 regulation during infectious colitis: implications for diseasedependent drug–drug interactions. Pharmacol Res Perspect. 2014; 2(1):e00027.
Parmentier JH, Schohn H, Bronner M, Ferrari L, Batt AM, Dauça M, Kremers, P. Regulation of CYP4A1 and peroxisome proliferator-activated receptor alpha expression by interleukin Iβ, interleukhv 6, and dexamethasone in cultured fetal rat hepatocytes. Biochem Pharmacol. 1997; 54(8):889- 898.
Knickle LC, Spencer DF, Renton KW. The suppression of hepatic cytochrome P4504A mRNA mediated by the interferon inducer polyinosinic acid-polycytidylic acid. Biochem Pharmacol. 1992; 44(3):604-608.
Wang L, Huang QH, Li YX, Huang YF, Xie JH, Xu LQ, Chen JN. Protective effects of silymarin on triptolideinduced acute hepatotoxicity in rats. Mol Med Rep. 2018; 17(1):789-800.
Mata-Santos HA, Dutra FF, Rocha CC, Lino FG, Xavier FR, Chinalia LA, dos Santos Pyrrho A. Silymarin reduces profibrogenic cytokines and reverses hepatic fibrosis in chronic murine schistosomiasis. Antimicrob Agents Chemother. 2014; 58(4):2076-2083.